RXST RxSight, Inc.

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.

$13.94  +0.17 (1.24%)
As of 06/28/2022 14:41:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  07/30/2021
Outstanding shares:  27,505,143
Average volume:  148,233
Market cap:   $383,696,745
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMJ0GR3
Valuation   (See tab for details)
PE ratio:   -6.45
PB ratio:   3.11
PS ratio:   13.68
Return on equity:   -48.29%
Net income %:   -212.04%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy